TE
科技回声
首页24小时热榜最新最佳问答展示工作
GitHubTwitter
首页

科技回声

基于 Next.js 构建的科技新闻平台,提供全球科技新闻和讨论内容。

GitHubTwitter

首页

首页最新最佳问答展示工作

资源链接

HackerNews API原版 HackerNewsNext.js

© 2025 科技回声. 版权所有。

Personalized medicine: Time for one-person trials

16 点作者 michaelmachine大约 10 年前

1 comment

mlinksva大约 10 年前
&gt; Every day, millions of people are taking medications that will not help them. The top ten highest-grossing drugs in the United States help between 1 in 25 and 1 in 4 of the people who take them (see &#x27;Imprecision medicine&#x27;). For some drugs, such as statins — routinely used to lower cholesterol — as few as 1 in 50 may benefit. There are even drugs that are harmful to certain ethnic groups because of the bias towards white Western participants in classical clinical trials.<p>Those are stunningly small proportions. What is the explanation? People try out lots of drugs and stop taking those that seem not to be working?<p>The graphic in the article says the proportions are related to the <a href="https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Number_needed_to_treat" rel="nofollow">https:&#x2F;&#x2F;en.wikipedia.org&#x2F;wiki&#x2F;Number_needed_to_treat</a> but I think I&#x27;ll have to read that article several times to understand. :) Not clear what reference in the article (the Nature one) provides the proportions or NNT data, but the nearest footnote is paywalled anyway.
评论 #9475858 未加载